X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare GSK Consumer with TILAKNAGAR IND. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK CONSUMER vs TILAKNAGAR IND. - Comparison Results

GSK CONSUMER    Change

GSK Consumer dominates the Rs 26 bn Indian malted beverage market with a significant 70% share (in volume terms). Its white beverage brand 'Horlicks' pioneered the broadening of the malted beverage market in India. Horlicks alone, as a white beverage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK CONSUMER TILAKNAGAR IND. GSK CONSUMER/
TILAKNAGAR IND.
 
P/E (TTM) x 41.6 -1.4 - View Chart
P/BV x 9.2 - - View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 GSK CONSUMER   TILAKNAGAR IND.
EQUITY SHARE DATA
    GSK CONSUMER
Mar-18
TILAKNAGAR IND.
Mar-17
GSK CONSUMER/
TILAKNAGAR IND.
5-Yr Chart
Click to enlarge
High Rs6,79320 33,626.7%   
Low Rs4,91912 39,987.8%   
Sales per share (Unadj.) Rs1,026.338.9 2,640.8%  
Earnings per share (Unadj.) Rs166.5-22.2 -750.1%  
Cash flow per share (Unadj.) Rs181.8-19.1 -949.9%  
Dividends per share (Unadj.) Rs75.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs828.6-1.8 -44,888.0%  
Shares outstanding (eoy) m42.06124.76 33.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.70.4 1,364.5%   
Avg P/E ratio x35.2-0.7 -4,804.1%  
P/CF ratio (eoy) x32.2-0.8 -3,793.5%  
Price / Book Value ratio x7.1-8.8 -80.3%  
Dividend payout %45.10-   
Avg Mkt Cap Rs m246,2842,027 12,148.1%   
No. of employees `0004.00.4 1,118.8%   
Total wages/salary Rs m5,277257 2,055.8%   
Avg. sales/employee Rs Th10,837.313,619.5 79.6%   
Avg. wages/employee Rs Th1,325.0721.1 183.7%   
Avg. net profit/employee Rs Th1,757.7-7,777.0 -22.6%   
INCOME DATA
Net Sales Rs m43,1654,849 890.3%  
Other income Rs m2,57441 6,232.7%   
Total revenues Rs m45,7394,890 935.4%   
Gross profit Rs m8,834-940 -939.7%  
Depreciation Rs m644381 168.8%   
Interest Rs m201,564 1.3%   
Profit before tax Rs m10,744-2,844 -377.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3,743-76 -4,950.5%   
Profit after tax Rs m7,001-2,769 -252.9%  
Gross profit margin %20.5-19.4 -105.6%  
Effective tax rate %34.82.7 1,310.6%   
Net profit margin %16.2-57.1 -28.4%  
BALANCE SHEET DATA
Current assets Rs m45,6206,625 688.6%   
Current liabilities Rs m17,42610,809 161.2%   
Net working cap to sales %65.3-86.3 -75.7%  
Current ratio x2.60.6 427.1%  
Inventory Days Days3558 59.8%  
Debtors Days Days2484 28.0%  
Net fixed assets Rs m5,1386,424 80.0%   
Share capital Rs m4211,248 33.7%   
"Free" reserves Rs m34,431-1,478 -2,329.7%   
Net worth Rs m34,851-230 -15,133.0%   
Long term debt Rs m01,901 0.0%   
Total assets Rs m54,12713,473 401.8%  
Interest coverage x530.2-0.8 -64,787.9%   
Debt to equity ratio x0-8.3 0.0%  
Sales to assets ratio x0.80.4 221.6%   
Return on assets %13.0-8.9 -145.1%  
Return on equity %20.11,202.2 1.7%  
Return on capital %30.9-76.6 -40.3%  
Exports to sales %00.3 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA13 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3,01413 22,492.2%   
Fx outflow Rs m1860 77,316.7%   
Net fx Rs m2,82813 21,492.4%   
CASH FLOW
From Operations Rs m7,23096 7,516.0%  
From Investments Rs m-4,465-3 148,816.7%  
From Financial Activity Rs m-3,634-120 3,035.9%  
Net Cashflow Rs m-868-26 3,288.3%  

Share Holding

Indian Promoters % 0.0 55.0 -  
Foreign collaborators % 72.5 0.0 -  
Indian inst/Mut Fund % 0.8 0.2 470.6%  
FIIs % 12.0 0.9 1,333.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 14.8 43.9 33.7%  
Shareholders   26,457 37,604 70.4%  
Pledged promoter(s) holding % 0.0 85.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK CONSUMER With:   ZYDUS WELLNESS  LAKSHMI OVERSEAS IND.  REI AGRO LTD.  RUCHI SOYA INDUSTRIES  HERITAGE FOOD  

Compare GSK CONSUMER With:   COCA COLA (US)  NESTLE (Switz.)  TIGER BRANDS (S. Africa)  AVI LTD. (S. Africa)  



Today's Market

Sensex Ends 170 Points Lower, Realty and FMCG Stocks Witness Selling(Closing)

After opening the day on a positive note, share markets in India witnessed volatile trading activity and ended in red.

Related Views on News

GSK CONSUMER Announces Quarterly Results (1QFY19); Net Profit Up 51.6% (Quarterly Result Update)

Aug 8, 2018 | Updated on Aug 8, 2018

For the quarter ended June 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 51.6% YoY). Sales on the other hand came in at Rs 11 bn (up 5.9% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

GSK CONSUMER Announces Quarterly Results (4QFY18); Net Profit Up 20.4% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, GSK CONSUMER has posted a net profit of Rs 2 bn (up 20.4% YoY). Sales on the other hand came in at Rs 12 bn (down 2.4% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.

Bajaj Corp: Slow Recovery from GST Implementation (Quarterly Results Update - Detailed)

Nov 10, 2017

A slow recovery from GST implementation and strained wholesale volumes puts pressure on Bajaj Corp's revenues.

ITC: GST Cess Weighs on Cigarettes (Quarterly Results Update - Detailed)

Nov 7, 2017

Additional cess in the GST regime hurts ITC's cigarette business.

Prataap Snacks Ltd. (IPO)

Sep 21, 2017

Is the Prataap Snacks IPO worth your attention?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

The Secret Of Mirae Asset India Equity Fund's Increasing Popularity(Outside View)

Sep 7, 2018

The prudent investment strategies followed at the fund house has helped Mirae Asset India Equity Fund earn a tag of being a consistent performer, which is in turn gaining popularity among investors.

Should You Be Worried About the Rising Dollar?(Chart Of The Day)

Sep 7, 2018

While the rupee has deprecated by about 5% annually since 1990 against the dollar, the BSE Sensex has returned 14% annually in the same period.

Revenge of the Ratings Agencies(Vivek Kaul's Diary)

Sep 7, 2018

Do you remember when ratings agencies ruled financial markets? Nick explains why he thinks it's time to prepare yourselves for a comeback of the ratings agencies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK CONSUMER SHARE PRICE


Sep 19, 2018 (Close)

TRACK GSK CONSUMER

  • Track your investment in GSK CONSUMER with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK CONSUMER - AVANTI FEEDS COMPARISON

COMPARE GSK CONSUMER WITH

MARKET STATS